Literature DB >> 29911906

Treatment of Class III malocclusion using miniscrew-anchored inverted Forsus FRD: Controlled clinical trial.

Osama Eissa, Mahmoud ElShennawy, Safaa Gaballah, Ghada ElMehy, Tarek El-Bialy.   

Abstract

OBJECTIVES: : To evaluate the skeletal, dental, and soft tissue changes after the use of miniscrew-anchored inverted Forsus fatigue-resistant device (FRD) in treatment of Class III malocclusion.
MATERIALS AND METHODS: : In this controlled clinical trial, 16 patients (9 girls and 7 boys; age 12.45 ± 0.87 years) were consecutively treated with miniscrew-anchored inverted Forsus FRD. This group was compared with a matched control group of 16 untreated patients (8 girls and 8 boys; age 11.95 ± 1.04 years). Miniscrews were inserted bilaterally between the maxillary canine and first premolar. Forsus FRD was selected and inserted in an inverted manner mesial to the mandibular headgear tube and distal to the maxillary canine bracket.
RESULTS: : Class I molar and canine relationships with positive overjet were achieved in an average period of 6.4 ± 1.46 months. Maxillary forward growth showed a statistically significant increase (SNA°: 1.73 ± 0.53, P < .5), maxillary incisor proclination was statistically significant (U1 to NA°: -0.39 ± 0.33, P > .5), and the lower incisors exhibited significant retroclination (L1 to NB°: 1.65 ± 0.83, P < .5). Significant lower lip retrusion and upper lip protrusion were obvious treatment outcomes ( P < .5).
CONCLUSIONS: : The use of miniscrew-anchored inverted FRD could effectively increase maxillary forward growth, but it did not prevent mesial movement of the maxillary dentition. Significant lower incisor retroclination was observed. Significant esthetic improvement of the facial profile was achieved primarily because of lower lip retrusion and upper lip protrusion.

Entities:  

Keywords:  Class III malocclusion; Fixed functional appliance; Forsus; Miniscrew

Mesh:

Year:  2018        PMID: 29911906      PMCID: PMC8174073          DOI: 10.2319/110717-760.1

Source DB:  PubMed          Journal:  Angle Orthod        ISSN: 0003-3219            Impact factor:   2.079


  15 in total

1.  Class III Twin Blocks: a case series.

Authors:  G Kidner; A DiBiase; D DiBiase
Journal:  J Orthod       Date:  2003-09

2.  The Forsus Fatigue Resistant Device.

Authors:  William Vogt
Journal:  J Clin Orthod       Date:  2006-06

3.  [Skeletal Class II treatment with the miniscrew-anchored Herbst].

Authors:  Cesare Luzi; Valeriano Luzi
Journal:  Orthod Fr       Date:  2013-11-27

4.  Nonsurgical Correction of Severe Skeletal Class III Malocclusion.

Authors:  Luis Carriére
Journal:  J Clin Orthod       Date:  2016-04

5.  The Function Regulator III: effects and indications for use.

Authors:  M K Loh; W J Kerr
Journal:  Br J Orthod       Date:  1985-07

6.  Maxillary retrusion in Class 3 and treatment with the function corrector 3.

Authors:  R Fränkel
Journal:  Rep Congr Eur Orthod Soc       Date:  1970

7.  Psychological issues in orthodontic practice.

Authors:  R I Story
Journal:  Am J Orthod       Date:  1966-08

8.  Chin-cap treatment for Angle Class 3 malocclusion.

Authors:  B Thilander
Journal:  Rep Congr Eur Orthod Soc       Date:  1965

9.  Treatment outcomes of Class II malocclusion cases treated with miniscrew-anchored Forsus Fatigue Resistant Device: A randomized controlled trial.

Authors:  Osama Eissa; Mahmoud El-Shennawy; Safaa Gaballah; Ghada El-Meehy; Tarek El Bialy
Journal:  Angle Orthod       Date:  2017-09-08       Impact factor: 2.079

10.  Long-term effects of chincap therapy on skeletal profile in mandibular prognathism.

Authors:  J Sugawara; T Asano; N Endo; H Mitani
Journal:  Am J Orthod Dentofacial Orthop       Date:  1990-08       Impact factor: 2.650

View more
  1 in total

1.  Reverse Forsus vs. facemask/rapid palatal expansion appliances in growing subjects with mild class III malocclusions : A randomized controlled clinical study.

Authors:  Mehmet Ali Yavan; Aysegul Gulec; Metin Orhan
Journal:  J Orofac Orthop       Date:  2021-07-16       Impact factor: 1.938

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.